Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 2 Interventional

Efficacy Study of Auriclosene Irrigation Solution on Urinary Catheter Patency

ClinicalTrials.gov ID: NCT02130518

Public ClinicalTrials.gov record NCT02130518. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 11:01 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Efficacy Study of Auriclosene Irrigation Solution on Indwelling Urinary Catheter Patency

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Long-term indwelling urinary catheters are associated with chronic recurrent urinary tract infections and blockage caused by crystalline biofilm accumulation (encrustation) of the catheter surfaces. When the urine and catheter are colonized by urease-producing bacteria such as Proteus mirabilis, encrustation of the catheter is likely to occur. The use of a catheter irrigation solution that can prevent biofilm formation and encrustation leading to blockage may keep the catheter patent longer, resulting in fewer catheter changes, potentially lower incidence of UTIs and better patient quality of life. Auriclosene is a non-antibiotic, fast-acting, broad-spectrum antimicrobial, which exhibits potential for the rapid decolonization of a range of urologic pathogens, including the urease-producing Proteus mirabilis. Subjects will be randomized to either Auriclosene Irrigation Solution or Auriclosene Vehicle solution.

Study identification

NCT ID
NCT02130518
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 2
Lead sponsor
NovaBay Pharmaceuticals, Inc.
Industry
Enrollment
140 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2014 (Type not available)
Primary completion
Dec 2015 (Estimated)
Completion
Jan 2016 (Estimated)
Last update posted
Dec 2, 2015

2014 – 2016

United States locations

U.S. sites
17
U.S. states
10
U.S. cities
17
Facility City State ZIP Site status
Los Amigos Research and Education Institute Downey California 90242 —
VA Long Beach Healthcare System Long Beach California 90822 —
Southern California Permanente Medical Group Los Angeles California 90027 —
Chesapeake Urology Research Associates Owings Mills Maryland 21117 —
Lahey Hospital and Medical Clinic Burlington Massachusetts 01805 —
Urology Center Research Institute Englewood New Jersey 07631 —
Delaware Valley Urology, LLC Voorhees Township New Jersey 08043 —
Kessler Institute for Rehabilitation West Orange New Jersey 07052 —
Urology Group of New Mexico Albuquerque New Mexico 87109 —
The Urological Institute of Northeastern NY Albany New York 12208 —
McKay Urology Charlotte North Carolina 28207 —
Eastern Urological Associates Greenville North Carolina 27834 —
Peters Medical Research High Point North Carolina 27262 —
Great Lakes Medical Research Mentor Ohio 44060 —
McGuire Veterans Affairs Medical Center Richmond Virginia 23249 —
Dean Clinic Madison Wisconsin 53715 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02130518, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 2, 2015 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02130518 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →